Developmental Oncology Symposium

Share
Print
Share
Print
Developmental Oncology Symposium

The Developmental Oncology Symposium aims to bring outstanding scientists across the country to discuss the latest discoveries into the molecular mechanisms of cancers in children and young adults, and the development of new approaches for their definitive therapy and control.

There are many unanswered questions that need to be addressed for childhood and young adult cancers:

  • What causes cancer in children and young adults without inheritance of cancer-predisposing mutations or exposure to environmental mutagens? How do predisposing alleles and exposures contribute to cancer development?
  • What developmental processes are dysregulated to cause mutations and cell transformation in otherwise healthy tissues?
  • How do mutations in developmental pathways involving transcription factors and epigenetic signaling cause cancer?
  • How do we design effective therapeutics to block, activate, and modulate protein interactions that control transcription factors and other developmental regulators?
  • How do we identify targets for immune therapy in developmental tumors that have relatively few mutations?

The Developmental Oncology Symposium provides an intimate and exciting setting to share new advances for these questions. This meeting also provides an opportunity for established and young investigators to discuss new questions and interdisciplinary approaches of relevance to young-onset cancer biology.

2022 New York Developmental Oncology Symposium

The 2022 Developmental Oncology Symposium will be held in New York City.

The 2022 Developmental Oncology Symposium will be held in New York City.

Speakers

  • Kimberly Stegmaier, MD: Dana-Farber Cancer Institute, Harvard Medical School
  • Charles Roberts, MD, PhD: St. Jude Children’s Research Hospital
  • Claudia Kleinman, PhD: McGill University
  • Sam Behjati, BMBCh, PhD: Wellcome Sanger Institute, Cambridge University
  • Miguel Rivera, MD: Massachusetts General Hospital, Harvard Medical School
  • John Maris, MD: Children’s Hospital of Philadelphia, Perelman School of Medicine
  • Michelle Monje-Deisseroth, MD, PhD: Stanford University

Additional speakers will be selected from submitted abstracts.

Program

  • Arrival, Sunday, May 1, 2022
    • Hotel check-in, Dinner
  • Monday, May 2, 2022
    • Talks with social breaks and lunch, followed by reception
  • Tuesday, May 3, 2022
    • Talks with lunch
    • Departure